4//SEC Filing
Voermann Karsten 4
Accession 0001809519-23-000057
CIK 0001809519other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:18 PM ET
Size
8.3 KB
Accession
0001809519-23-000057
Insider Transaction Report
Form 4
Voermann Karsten
Chief Financial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2023-12-08+54,064→ 199,885 total - Exercise/Conversion
Restricted Stock Unit
2023-12-08−54,064→ 594,704 total→ Class A Common Stock (54,064 underlying) - Tax Payment
Class A Common Stock
2023-12-08$5.94/sh−24,757$147,057→ 175,128 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
Documents
Issuer
GoodRx Holdings, Inc.
CIK 0001809519
Entity typeother
Related Parties
1- filerCIK 0001822140
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 5:18 PM ET
- Size
- 8.3 KB